Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome.
Intercity Hospital of Creteil, Creteil University Eye Clinic, UPEC, Créteil, France.
Eric H
EH
Souied
Salomon-Yves
SY
Cohen
Gérard
G
de Pouvourville
Gérard
G
Dupeyron
Elisabeth
E
Latour
Anne
A
Ponthieux
Michel
M
Weber
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005602:France; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology*; D057135:Wet Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab